MediPharm Labs Corp (MEDIF)

[cure627]

from Mathew Carr, profit trends publications:

The best performers so far are MediPharm Labs (OTC: MEDIF), Innovative Industrial Properties and GrowGeneration. These three are up more than 95% each so far in 2019, despite significant pullbacks from their year-to-date highs.

They’ve weathered the storm and are still in the green.

The three underperformers are OrganiGram Holdings (Nasdaq: OGI), CV Sciences and MariMed (OTC: MRMD).

It’s worth noting that MediPharm and OrganiGram were the only two Canadian companies in the top 10 for adjusted operating income. This shows that American CBD makers and MSOs have strong markets to tap into – and likely some very serious upside.